LifeMap Sciences' VarElect

LifeMap Sciences, a subsidiary of BioTime, has released VarElect, an application for prioritizing gene variants from next-generation sequencing experiments. According to the company, the tool prioritizes variants based on their potential association to disease or phenotypes of interest.


Bio-Rad ddPCR KRAS Screening Multiplex Kit

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.